乐观
$140.04
情景价格
$126.540
-0.025 (-0.02%)收盘时
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Integer Holdings Corp is currently not a strong buy due to its recent downgrades and market uncertainties. The stock is trading at $126.54, just below the acquisition price of $127, indicating limited upside potential. The RSI is at 37.997, suggesting it is nearing oversold territory, but the lack of a clear growth outlook and the withdrawal of guidance due to the acquisition creates uncertainty. The main risk is the projected sales growth slowing to 1.6% over the next 12 months, which could impact profitability.
Benchmark
—
2026-08-13
Benchmark
2026-08-13
目标价
—
Piper Sandler
$127
2026-08-03
Piper Sandler
2026-08-03
目标价
$127
KeyBanc
$127
2026-08-03
KeyBanc
2026-08-03
目标价
$127
BofA
—
2026-08-03
BofA
2026-08-03
目标价
—
Freedom Capital
$112
2026-07-22
Freedom Capital
2026-07-22
目标价
$112
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Integer Holdings Shareholders Approve Merger Proposals

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Investor Rights Law Firm Investigates Multiple Companies

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Investor Rights Law Firm Investigates Multiple Companies
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
Integer Holdings Corp is currently not a strong buy due to its recent downgrades and market uncertainties. The stock is trading at $126.54, just below the acquisition price of $127, indicating limited upside potential. The RSI is at 37.997, suggesting it is nearing oversold territory, but the lack of a clear growth outlook and the withdrawal of guidance due to the acquisition creates uncertainty. The main risk is the projected sales growth slowing to 1.6% over the next 12 months, which could impact profitability.
5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。